120 related articles for article (PubMed ID: 37321906)
1. Harmful impact of treatment refusal in T3-4M0 endolaryngeal squamous cell carcinoma candidates for total laryngectomy: A STROBE analysis.
Laccourreye O; Gervais C; Garcia D; Amiri G; Mirghani H; Giraud P
Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Sep; 140(5):221-225. PubMed ID: 37321906
[TBL] [Abstract][Full Text] [Related]
2. Primary Total Laryngectomy for Endolaryngeal cT3-4M0 Squamous Cell Carcinoma: A STROBE Analysis.
Laccourreye O; Garcia D; Haroun F; Nguyen DH; Giraud P; Mirghani H
Laryngoscope; 2024 May; 134(5):2288-2294. PubMed ID: 37921374
[TBL] [Abstract][Full Text] [Related]
3. Successful 10-year outcomes after supracricoid partial laryngectomy for selected glottic squamous cell carcinoma classified as T3N0M0: A STROBE analysis.
Laccourreye O; Chambrin G; Garcia D; Troux C; Mirghani H; Giraud P
Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Aug; 140(4):165-170. PubMed ID: 36609114
[TBL] [Abstract][Full Text] [Related]
4. Total laryngectomy for laryngeal cancer 150 years after its first description: A boon more than a calamity: A STROBE analysis.
Laccourreye O; Garcia D; Mudry A
Eur Ann Otorhinolaryngol Head Neck Dis; 2023 Jan; 140(1):25-29. PubMed ID: 36210325
[TBL] [Abstract][Full Text] [Related]
5. Neo-adjuvant chemotherapy and supracricoid partial laryngectomy with cricohyoidopexy for advanced endolaryngeal carcinoma classified as T3-T4: 5-year oncologic results.
Laccourreye O; Brasnu D; Biacabe B; Hans S; Seckin S; Weinstein G
Head Neck; 1998 Oct; 20(7):595-9. PubMed ID: 9744458
[TBL] [Abstract][Full Text] [Related]
6. Local control after supracricoid partial laryngectomy for "advanced" endolaryngeal squamous cell carcinoma classified as T3.
Dufour X; Hans S; De Mones E; Brasnu D; Ménard M; Laccourreye O
Arch Otolaryngol Head Neck Surg; 2004 Sep; 130(9):1092-9. PubMed ID: 15381597
[TBL] [Abstract][Full Text] [Related]
7. Failed larynx preservation and survival in patients with advanced larynx cancer.
Nocon CC; Yesensky J; Ajmani GS; Bhayani MK
Am J Otolaryngol; 2019; 40(4):542-546. PubMed ID: 31036417
[TBL] [Abstract][Full Text] [Related]
8. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
Woodard TD; Oplatek A; Petruzzelli GJ
Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
[TBL] [Abstract][Full Text] [Related]
9. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
[TBL] [Abstract][Full Text] [Related]
10. Elective neck dissection in the treatment of T3/T4 N0 squamous cell carcinoma of the larynx.
Kligerman J; Olivatto LO; Lima RA; Freitas EQ; Soares JR; Dias FL; Melo LE; Sá GM; Duccini E
Am J Surg; 1995 Nov; 170(5):436-9. PubMed ID: 7485727
[TBL] [Abstract][Full Text] [Related]
11. Long-term outcomes after multidisciplinary management of T3 laryngeal squamous cell carcinomas: Improved functional outcomes and survival with modern therapeutic approaches.
Fuller CD; Mohamed AS; Garden AS; Gunn GB; Mulcahy CF; Zafereo M; Phan J; Lai SY; Lewin JS; Hutcheson KA; Frank SJ; Beadle BM; Morrison WH; El-Naggar AK; Kocak-Uzel E; Ginsberg LE; Kies MS; Weber RS; Rosenthal DI
Head Neck; 2016 Dec; 38(12):1739-1751. PubMed ID: 27466789
[TBL] [Abstract][Full Text] [Related]
12. Outcomes following laryngectomy refusal after insufficient response to induction chemotherapy.
Gorphe P; Matias M; Blanchard P; Even C; Ferte C; Tao Y; Temam S; Bidault F; Janot F
Laryngoscope; 2017 Aug; 127(8):1791-1796. PubMed ID: 27888508
[TBL] [Abstract][Full Text] [Related]
13. Laryngeal recurrence sites in patients previously treated with transoral laser microsurgery for squamous cell carcinoma.
Horwich P; Rigby MH; MacKay C; Melong J; Williams B; Bullock M; Hart R; Trites J; Taylor SM
J Otolaryngol Head Neck Surg; 2018 Feb; 47(1):14. PubMed ID: 29433567
[TBL] [Abstract][Full Text] [Related]
14. Horizontal supraglottic partial laryngectomy for selected squamous carcinoma of the vallecula.
Laccourreye L; Garcia D; Ménard M; Brasnu D; Laccourreye O; Holsinger FC
Head Neck; 2008 Jun; 30(6):756-64. PubMed ID: 18286490
[TBL] [Abstract][Full Text] [Related]
15. Supracricoid partial laryngectomy for primary and recurrent laryngeal cancer.
Sperry SM; Rassekh CH; Laccourreye O; Weinstein GS
JAMA Otolaryngol Head Neck Surg; 2013 Nov; 139(11):1226-35. PubMed ID: 24092390
[TBL] [Abstract][Full Text] [Related]
16. Oncological outcomes of surgical treatment for T3 supraglottic laryngeal squamous cell carcinoma patients.
Zhou J; Zhou L; Tao L; Zhang M; Wu H; Chen X; Li X; Li C; Gong H
Acta Otolaryngol; 2018 Nov; 138(11):1028-1034. PubMed ID: 30735065
[TBL] [Abstract][Full Text] [Related]
17. Primary Laryngectomy Versus Salvage Laryngectomy: A Comparison of Outcomes in the Chemoradiation Era.
Sullivan CB; Ostedgaard KL; Al-Qurayshi Z; Pagedar NA; Sperry SM
Laryngoscope; 2020 Sep; 130(9):2179-2185. PubMed ID: 31654445
[TBL] [Abstract][Full Text] [Related]
18. Supraglottic laryngeal cancer: analysis of treatment results.
Sessions DG; Lenox J; Spector GJ
Laryngoscope; 2005 Aug; 115(8):1402-10. PubMed ID: 16094113
[TBL] [Abstract][Full Text] [Related]
19. Middle frontal horizontal partial laryngectomy (MFHPL): a treatment for stage T1b squamous cell carcinoma of the glottic larynx involving anterior vocal commissure.
Lei WB; Jiang AY; Chai LP; Zhu XL; Wang ZF; Wen YH; Su ZZ; Wen WP
PLoS One; 2013; 8(1):e52723. PubMed ID: 23326350
[TBL] [Abstract][Full Text] [Related]
20. A change in the study evaluation paradigm reveals that larynx preservation compromises survival in T4 laryngeal cancer patients.
Dyckhoff G; Plinkert PK; Ramroth H
BMC Cancer; 2017 Sep; 17(1):609. PubMed ID: 28863776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
